1 Q. M. Anstee, A. K. Daly, and C. P. Day, Genetics of Alcoholic and Nonalcoholic Fatty

1 Q. M. Anstee, A. K. Daly, and C. P. Day, Genetics of Alcoholic and Nonalcoholic Fatty

EGR1 / [1]
AP1 / [1]
STAT1 / [2]
TLR4 / [1, 3, 4]
CD14 / [1, 3, 5]
LBP / [1, 5]
LY96 / [1]
IKBKB / [1, 6]
SOD2 / [1, 3, 7]
FOS / [8]
JUN / [8]
NPY / [9]
GSK3B / [5, 10]
CYP2E1 / [1, 3, 5, 7, 11]
SETD2 / [12]
PAI1 / [7]
PAR1 / [5]
CD28 / [3]
CD95 / [3, 5]
TNFRSF1A / [13]
TNFS10 / [13]
PPARA / [1, 3]
IL1B / [1, 2, 4, 14]
ADH / [1, 3]
ALDH / [1, 3]
GST / [1, 3]
IL10 / [1-3]
NFKB1 / [1, 12]
TGFB1 / [1-4, 7, 13, 15]
TNF / [1-4, 6-8, 14, 15]
GABRAB1 / [1]
CTLA4 / [2, 3]
ANXA2 / [5, 13, 16]
S100A10 / [5, 16]
PAI1 / [5, 16]
PLG / [5, 16]
PLAU / [5, 16]
SERPINF2 / [16]
ACTB / [5, 6, 16]
CALCRL / [5]
EDG1 / [5]
FRZB / [5]
GNB1 / [5]
CITED2 / [5]
RGS5 / [5]
MT1L / [5]
SOD1 / [5]
CANP / [5]
MCP1 / [4-7, 14]
AEBP1 / [5]
MSP / [5]
SREBP1 / [3, 12]
MAPK / [12]
MCD / [8]
PPRE / [11, 14]
CPTI / [1, 8, 11, 14]
RXRA / [17, 18]
SAM / [13]
MGSH / [19, 20]
MAT2A / [3]
MAT1A / [3][3, 13]
ERK2 / [12, 14, 21]
LPS / [1, 3, 4, 14]
TIMP1 / [7]

[1]Q. M. Anstee, A. K. Daly, and C. P. Day, "Genetics of alcoholic and nonalcoholic fatty liver disease," in Seminars in liver disease, 2011, pp. 128-146.

[2]N. Roy, I. Mukhopadhyay, K. Das, P. Pandit, P. P. Majumder, A. Santra, et al., "Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population," Gene, vol. 509, pp. 178-188, 2012.

[3]C. Day, "Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease," Liver International, vol. 26, pp. 1021-1028, 2006.

[4]S. Fleming, S. Toratani, T. Shea‐Donohue, Y. Kashiwabara, S. N. Vogel, and E. S. Metcalf, "Pro‐and Anti‐Inflammatory Gene Expression in the Murine Small Intestine and Liver After Chronic Exposure to Alcohol," Alcoholism: Clinical and Experimental Research, vol. 25, pp. 579-589, 2001.

[5]D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, et al., "Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver," The American journal of pathology, vol. 163, pp. 2303-2317, 2003.

[6]A. A. Nanji, K. Jokelainen, G. L. Tipoe, A. Rahemtulla, P. Thomas, and A. J. Dannenberg, "Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 284, pp. G321-G327, 2003.

[7]J. Colmenero, R. Bataller, P. Sancho–Bru, P. Bellot, R. Miquel, M. Moreno, et al., "Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity," Gastroenterology, vol. 132, pp. 687-697, 2007.

[8]M. Liu, Y. Dou, R. Sun, Y. Zhang, and Y. Liu, "Molecular mechanisms for alcoholic hepatitis based on analysis of gene expression profile," Hepatitis monthly, vol. 15, 2015.

[9]V. Purohit, D. Russo, and P. M. Coates, "Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium," Alcohol, vol. 34, pp. 3-8, 2004.

[10]C. Desbois‐Mouthon, B. V. Eggelpoë, E. Beurel, M. Boissan, R. Delélo, A. Cadoret, et al., "Dysregulation of glycogen synthase kinase‐3β signaling in hepatocellular carcinoma cells," Hepatology, vol. 36, pp. 1528-1536, 2002.

[11]V. Purohit, B. Gao, and B. J. Song, "Molecular mechanisms of alcoholic fatty liver," Alcoholism: Clinical and Experimental Research, vol. 33, pp. 191-205, 2009.

[12]H.-Q. Yin, M. Kim, J.-H. Kim, G. Kong, K.-S. Kang, H.-L. Kim, et al., "Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice," Toxicology and applied pharmacology, vol. 223, pp. 225-233, 2007.

[13]D. Seth, M. D. Gorrell, S. Cordoba, G. W. McCaughan, and P. S. Haber, "Intrahepatic gene expression in human alcoholic hepatitis," Journal of hepatology, vol. 45, pp. 306-320, 2006.

[14]P. Mandrekar, A. Ambade, A. Lim, G. Szabo, and D. Catalano, "An essential role for monocyte chemoattractant protein‐1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice," Hepatology, vol. 54, pp. 2185-2197, 2011.

[15]S. Kamimura and H. Tsukamoto, "Cytokine gene expression by kupffer 4cells in experimental alcoholic liver disease," Hepatology, vol. 22, pp. 1304-1309, 1995.

[16]D. Seth, P. J. Hogg, M. D. Gorrell, G. W. McCaughan, and P. S. Haber, "Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease," Journal of hepatology, vol. 48, pp. 614-627, 2008.

[17]M. A. Gyamfi, M. G. Kocsis, L. He, G. Dai, A. J. Mendy, and Y.-J. Y. Wan, "The role of retinoid X receptor α in regulating alcohol metabolism," Journal of Pharmacology and Experimental Therapeutics, vol. 319, pp. 360-368, 2006.

[18]C. Wu, R. Gilroy, R. Taylor, M. Olyaee, B. Abdulkarim, J. Forster, et al., "Alteration of hepatic nuclear receptor‐mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking," Hepatology, vol. 54, pp. 1966-1974, 2011.

[19]J. C. Fernández-Checa, N. Kaplowitz, C. García-Ruiz, and A. Colell, "Mitochondrial glutathione: importance and transport," in Seminars in liver disease, 1998, pp. 389-401.

[20]K. J. Thompson, I. H. McKillop, and L. W. Schrum, "Targeting collagen expression in alcoholic liver disease," World Journal of Gastroenterology: WJG, vol. 17, p. 2473, 2011.

[21]L. Yang, D. Wu, and A. Cederbaum, "CYP2E1, oxidative stress and mapk signaling pathways in alcohol-induced hepatotoxicity," J. Biochem. Pharmacol. Res, vol. 2, pp. 74-90, 2014.